Cargando…
Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life
This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC). Patients with NPC who experienced moderate-to-severe oral...
Autores principales: | Guo, Su-Ping, Wu, San-Gang, Zhou, Juan, Feng, Hui-Xia, Li, Feng-Yan, Wu, Ying-Jia, Sun, Jia-Yuan, He, Zhen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026399/ https://www.ncbi.nlm.nih.gov/pubmed/24872680 http://dx.doi.org/10.2147/DDDT.S60187 |
Ejemplares similares
-
Transdermal Fentanyl for Chronic Low Back Pain
por: Ohtori, Seiji, et al.
Publicado: (2012) -
Fatal Overdose due to Confusion of an Transdermal Fentanyl Delivery System
por: Voigt, Ingo
Publicado: (2013) -
Does transdermal fentanyl work in patients with low BMI? Patient‐reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl
por: Moryl, Natalie, et al.
Publicado: (2019) -
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial
por: Hua, Xin, et al.
Publicado: (2019) -
Acute postoperative pain management: focus on iontophoretic transdermal fentanyl
por: Mattia, Consalvo, et al.
Publicado: (2007)